Healthcare/Diagnostics·Spring 2026
Adialante logo

Adialante

Cancer screening without barriers

Overview

One-liner
Cancer screening without barriers

Why it's interesting

Market trends shaping Adialante

  • 1Multi-cancer early detection (MCED) racing toward Medicare coverage
  • 2At-home sample collection finally reimbursed at parity in many states
  • 3AI radiology moving from triage to autonomous read in narrow indications
  • 4Liquid biopsy expanding from oncology to transplant and infectious disease
  • 5Wearable biosensors blurring the line between consumer and clinical
  • 6Lab-developed test rule changing the regulatory landscape overnight
Insights · email required

Unlock the 6 trends behind Adialante

Enter your email to read every market insight across all 377 startups — free.